Labcorp and Inspira Health Announce Strategic Agreement For Lab Operations

Collaboration aims to improve access to innovative diagnostic testing and laboratory services for patients and providers throughout Southern New Jersey

BURLINGTON, N.C., (Jan. 9, 2025) - Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a strategic collaboration with Inspira Health to manage the daily operations of the health system's hospital laboratories located in Vineland, Elmer and Mullica Hill, New Jersey. Additionally, Labcorp will begin to serve as the primary lab for Inspira's physician network.

The new relationship combines important capabilities, experience and technologies from both organizations to enhance access to laboratory services and further the delivery of high-quality patient care. Labcorp will provide staffing, leadership, scientific knowledge, analytics, supply chain services and laboratory and technical support to Inspira's inpatient hospital laboratories.

"Labcorp is focused on delivering high-quality, efficient laboratory testing to health systems, physicians, patients, and health plans," said Bill Haas, Senior Vice President of Labcorp's Northeast Division. "We look forward to working with Inspira to realize our shared mission to improve health outcomes in the communities we serve."

Inspira's more than 1,400 physicians will benefit from Labcorp's scientific leadership and advanced diagnostics in important clinical areas such as oncology, neurology, autoimmune disease, and women's health, as well as gain access to Labcorp's convenient at-home test collection services to advance patient care.

"This strategic relationship enables Inspira Health to leverage Labcorp's leading clinical laboratory services and robust data and digital tools to improve the health and well-being of our community" said Warren E. Moore, FACHE, Executive Vice President and Chief Operating Officer, Inspira Health. "By connecting our mission-driven organizations, we will achieve improvements and innovations that will benefit our patients and providers."

This relationship follows other strategic collaborations that Labcorp has established with a range of health systems across the country focused on enhancing service for patients and providers.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.

SOURCE Labcorp

Labcorp Contacts: Investors: [email protected]; Media: [email protected]